Brief: Exscientia And MD Anderson Launch Strategic Collaboration To Leverage Ai In Developing Novel Oncology Treatments
14/11/2022 13:06
Nov 14 (Reuters) - Exscientia PLC EXAI.O :
* EXSCIENTIA AND MD ANDERSON LAUNCH STRATEGIC COLLABORATION
TO
LEVERAGE AI IN DEVELOPING NOVEL ONCOLOGY TREATMENTS
Source text for Eikon: ID:nBw9YvLy3a
Further company coverage: EXAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Exscientia
See all newsExscientia PLC expected to post a loss of 9 cents a share - Earnings Preview
Brief: Exscientia Achieves Milestones For Two Programmes In Sanofi Collaboration
Exscientia PLC reports results for the quarter ended in June - Earnings Summary
Deals of the day-Mergers and acquisitions
Biotech firm Recursion to buy smaller peer Exscientia for $688 million